Literature DB >> 12714791

A plurihormonal TSH-producing pituitary tumor of monoclonal origin in a patient with hypothyroidism.

Wenbin Ma1, Hidetoshi Ikeda, Noriaki Watabe, Mitsunobu Kanno, Takashi Yoshimoto.   

Abstract

OBJECTIVE: A clinicopathological and clonal study of a pituitary tumor was made in a 26-year-old woman with chronic thyroiditis to differentiate TSH-producing adenoma from TSH hyperplasia.
METHODS: Tumor specimens were subjected to histopathological study and clonal analysis (HUMARA).
RESULTS: Immunohistochemical examination disclosed TSH-beta, PRL, GH, ACTH, FSH-beta, LH-beta, and alpha-subunit production in the adenoma cells. These heterogeneous phenotypes are characteristic of both thyrotroph hyperplasia and plurihormonal TSH-producing adenoma. However, the HUMARA method demonstrated monoclonality of the tumor cells.
CONCLUSION: Monoclonality of the tumor cells proved that the pituitary tumor was plurihormonal TSH-producing adenoma, not TSH hyperplasia. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714791     DOI: 10.1159/000070227

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  5 in total

1.  2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.

Authors:  P Beck-Peccoz; A Lania; A Beckers; K Chatterjee; J-L Wemeau
Journal:  Eur Thyroid J       Date:  2013-05-07

2.  Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism.

Authors:  M Losa; P Mortini; R Minelli; M Giovanelli
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

3.  Somatotroph to thyrotroph cell transdifferentiation during experimental hypothyroidism - a light and electron-microscopy study.

Authors:  S Radian; M Coculescu; J F Morris
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

4.  A Thyroid-stimulating Hormone (TSH) Producing Adenoma in a Patient with Severe Hypothyroidism: Thyroxine Replacement Reduced the TSH Level and Tumor Size.

Authors:  Hiroshi Arimura; Rofat Askoro; Shingo Fujio; Fauziah C Ummah; Tomoko Takajo; Yushi Nagano; Yoshihiko Nishio; Kazunori Arita
Journal:  NMC Case Rep J       Date:  2019-12-18

5.  Syndrome of inappropriate secretion of thyroid-stimulating hormone in a subject with galactorrhea and menstrual disorder and undergoing infertility treatment: Case report.

Authors:  Hideaki Kaneto; Shinji Kamei; Fuminori Tatsumi; Masashi Shimoda; Tomohiko Kimura; Atsushi Obata; Takatoshi Anno; Shuhei Nakanishi; Kohei Kaku; Tomoatsu Mune
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.